Pathology Services

Vipragen provides integrated pathology services for non-clinical safety, efficacy and translational research studies. Our integrated preclinical pathology services provide comprehensive, GLP-compliant evaluations critical for drug and medical device efficacy and safety assessments. These end-to-end solutions include clinical pathology, necropsy, routine/special staining techniques, immunohistochemistry (IHC) for biomarker expression, and expert pathology review across discovery, in vivo pharmacology and toxicology stages of development.

Vipragen's Pathology services include well-established tests and their respective methodologies and deliverables such as:

Species Supported

Our pathology services support a broad range of laboratory and large-animal species.

Integrated Pathology Support for Preclinical Studies

Pathology does not function as an isolated study endpoint. Its value comes from connecting clinical observations, laboratory parameters, tissue-level findings and biological mechanisms.

Vipragen’s integrated capabilities allow pathology assessments to be incorporated into:

• » Discovery and proof-of-concept studies


• » In vivo efficacy studies


• » General toxicology studies


• » Safety pharmacology programs


• » Nutraceutical and functional ingredient studies


• » Medical device studies


• » Veterinary product development


• » Study-specific biomarker investigations

Our team works with sponsors to select relevant pathology endpoints and align sample collection, analysis and tissue evaluation with the overall study design.

Discuss Your Pathology Requirements

Whether you require standalone sample analysis or pathology support integrated into a broader non-clinical study, Vipragen can develop a study-specific approach aligned with your research objectives.

Contact Our Team at bd@vipragen.com Or share your current study requirements at https://vipragen.com/contact-us.html